Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
COLL Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
COLL Stock 12 Month Forecast
Average Price Target
$45.50
▲(7.57% Upside)
| Highest Price Target$48.00 | Average Price Target$45.50 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
$45→$48
Buy
13.48%
Upside
Reiterated
11/07/25
TR | OpenAI - 4o
$37→$45
Buy
6.38%
Upside
Upgraded
11/07/25
AI Generated ArticleAI Generated Article
H.C. Wainwright
$44→$46
Buy
8.75%
Upside
Reiterated
11/07/25
Needham
$46→$48
Buy
13.48%
Upside
Reiterated
11/06/25
Analysts Are Bullish on These Healthcare Stocks: Collegium Pharmaceutical (COLL), Privia Health Group (PRVA)We maintain our Buy rating based on continued undervaluation of the co's topline growth, profitability, and revenue durability. We adjust our $PT to $48 (from $46) to reflect updated growth trends for Jornay PM.
Piper Sandler
$40
Hold
-5.44%
Downside
Reiterated
08/18/25
Jefferies
$40
Buy
-5.44%
Downside
Reiterated
03/17/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
$45→$48
Buy
13.48%
Upside
Reiterated
11/07/25
TR | OpenAI - 4o
$37→$45
Buy
6.38%
Upside
Upgraded
11/07/25
AI Generated ArticleAI Generated Article
H.C. Wainwright
$44→$46
Buy
8.75%
Upside
Reiterated
11/07/25
Needham
$46→$48
Buy
13.48%
Upside
Reiterated
11/06/25
Analysts Are Bullish on These Healthcare Stocks: Collegium Pharmaceutical (COLL), Privia Health Group (PRVA)We maintain our Buy rating based on continued undervaluation of the co's topline growth, profitability, and revenue durability. We adjust our $PT to $48 (from $46) to reflect updated growth trends for Jornay PM.
Piper Sandler
$40
Hold
-5.44%
Downside
Reiterated
08/18/25
Jefferies
$40
Buy
-5.44%
Downside
Reiterated
03/17/25
Best Analysts Covering Collegium Pharmaceutical
1 Month
xxx
Success Rate
16/29 ratings generated profit
Average Return
+0.28%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.17% of your transactions generating a profit, with an average return of +0.28% per trade.
3 Months
xxx
Success Rate
13/29 ratings generated profit
Average Return
+0.94%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.83% of your transactions generating a profit, with an average return of +0.94% per trade.
1 Year
Success Rate
18/29 ratings generated profit
Average Return
+11.92%
reiterated a buy rating 3 days ago
Copying Serge Belanger's trades and holding each position for 1 Year would result in 62.07% of your transactions generating a profit, with an average return of +11.92% per trade.
2 Years
xxx
Success Rate
22/29 ratings generated profit
Average Return
+26.93%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.86% of your transactions generating a profit, with an average return of +26.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
COLL Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
1
0
0
0
0
Buy
11
14
14
11
6
Hold
1
1
3
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
15
17
15
9
Each month's total comprises the sum of three months' worth of ratings.
COLL Financial Forecast
COLL Stock Forecast FAQ
What is COLL’s average 12-month price target, according to analysts?
Based on analyst ratings, Collegium Pharmaceutical’s 12-month average price target is 45.50.
What is COLL’s upside potential, based on the analysts’ average price target?
Collegium Pharmaceutical has 7.57% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is COLL a Buy, Sell or Hold?
Collegium Pharmaceutical has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Collegium Pharmaceutical’s price target?
The average price target for Collegium Pharmaceutical is 45.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $48.00 ,the lowest forecast is $40.00. The average price target represents 7.57% Increase from the current price of $42.3.
The highest analyst price target is $48.00 ,the lowest forecast is $40.00. The average price target represents 7.57% Increase from the current price of $42.3.
What do analysts say about Collegium Pharmaceutical?
Collegium Pharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of COLL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.